1-9 of 9
Anna Maria Scattolin, MD
Close
Sort by
Journal Articles

Identification of a Chromatin-Splicing Mutational Signature to Define Secondary Acute Myeloid Leukemia: A Report from the Northern Italy Leukemia Group (NILG) Prospective Trial 02/06

Chiara Caprioli, MD, Federico Lussana, MD, Silvia Salmoiraghi, BioSc, Roberta Cavagna, BioSc, Ksenija Buklijas, BioSc, Lara Elidi, BioSc, Pamela Zanghì, BioSc, Anna Michelato, PhD, Federica Delaini, MSc, Elena Oldani, MSc, Dario Ferrero, MD, Ernesta Audisio, MD, Filippo Marmont, MD, Elisabetta Terruzzi, MD, Lorella De Paoli, MD, Chiara Cattaneo, MD, Erika Borlenghi, MD, Irene Cavattoni, MD, Monica Tajana, MD, Anna Maria Scattolin, MD, Daniele Giovanni Mattei, MD, Paolo Corradini, Leonardo Campiotti, MD, Fabio Ciceri, MD, Massimo Bernardi, MD, Elisabetta Todisco, MD PhD, Agostino Cortelezzi, MD, Sergio Cortelazzo, MD, Giacomo Gianfaldoni, MD, Alberto Bosi, MD, Brunangelo Falini, MD PhD, Tamara Intermesoli, MD, Chiara Pavoni, Statistician, Renato Bassan, MD, Orietta Spinelli, PhD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1443.
https://doi.org/10.1182/blood-2019-124497
Published: 2019
Journal Articles

Clinical Impact of an Accurate Genetic Characterization of Older Acute Myeloid Leukemia Patients: A Report from the Northern Italy Leukemia Group (NILG) Randomized Trial 02/06

Chiara Caprioli, MD, Tamara Intermesoli, MD, Orietta Spinelli, PhD, Silvia Salmoiraghi, MSc, Pamela Zanghì, MSc, Roberta Cavagna, MSc, Anna Michelato, PhD, Ksenija Buklijas, MSc, Federica Delaini, MSc, Elena Oldani, MSc, Giacomo Gianfaldoni, MD, Dario Ferrero, MD, Elisabetta Terruzzi, MD, Lorella De Paoli, MD, Chiara Cattaneo, MD, Erika Borlenghi, MD, Irene Cavattoni, MD, Monica Tajana, MD, Anna Maria Scattolin, MD, Daniele Giovanni Mattei, MD, Paolo Corradini, MD, Leonardo Campiotti, MD, Fabio Ciceri, MD, Massimo Bernardi, MD, Elisabetta Todisco, MD, Agostino Cortelezzi, MD, Sergio Cortelazzo, MD, Ernesta Audisio, MD, Filippo Marmont, MD, Alberto Bosi, MD, Brunangelo Falini, MD PhD, Chiara Pavoni, Statistician, Renato Bassan, MD, Alessandro Rambaldi, MD, Federico Lussana, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 434.
https://doi.org/10.1182/blood-2018-99-113869
Published: 2018
Journal Articles

Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL)

Renato Bassan, MD, Arianna Masciulli, PharmD, Tamara Intermesoli, MD, Orietta Spinelli, PhD, Manuela Tosi, PhD, Chiara Pavoni, MSc, Ernesta Audisio, MD, Giuseppe Rossi, MD, Monica Fumagalli, MD, Vincenzo Cassibba, MD, Daniele Mattei, MD, Claudio Romani, MD, Agostino Cortelezzi, MD, Fabio Ciceri, MD, Anna Maria Scattolin, MD, Umberto Vitolo, MD, Erika Borlenghi, MD, Sergio Cortelazzo, MD, Andrea Gallamini, MD, Lorella Depaoli, MD, Leonardo Campiotti, MD, Monica Tajana, MD, Monica Bocchia, MD, Antonella Vitale, MD, Marco Ladetto, MD, Eros Di Bona, MD, Elena Oldani, BiolSc, Alessandro Rambaldi, MD
Journal: Blood
Blood (2016) 128 (22): 176.
https://doi.org/10.1182/blood.V128.22.176.176
Published: 2016
Journal Articles

Levels of Minimal Residual Disease Prior to Transplant Influence Outcome of Adult Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Federico Lussana, MD, Tamara Intermesoli, MD, Francesca Gianni, MD, Cristina Boschini, MSc, Arianna Masciulli, PhD MSc, Orietta Spinelli, PhD, Elena Oldani, BiolSc, Manuela Tosi, PhD, Rosa Maria Marfisi, MSc, Anna Grassi, MD, Margherita Parolini, MD, Ernesta Audisio, MD, Chiara Cattaneo, MD, Roberto Raimondi, MD, Emanuele Angelucci, MD, Irene Maria Cavattoni, MD, Anna Maria Scattolin, MD, Agostino Cortelezzi, MD, Francesco Mannelli, MD, Fabio Ciceri, MD, Daniele Mattei, MD, Erika Borlenghi, MD, Elisabetta Terruzzi, MD, Claudio Romani, MD, Renato Bassan, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2015) 126 (23): 4374.
https://doi.org/10.1182/blood.V126.23.4374.4374
Published: 2015
Journal Articles

The Long-Term Outcome Of Adult Patients With Acute Myeloid Leukemia NPM+ and FLT3/ITD- Is Not Significantly Improved By The Application Of An Allogeneic Stem Cell Transplantation

Tamara Intermesoli, MD, Marco Frigeni, MD, Elena Oldani, BiolSC, Pamela Zanghì, BiolSC, Orietta Spinelli, BiolSC, Alberto Bosi, MD, Filippo Marmont, MD, Giuseppe Rossi, Sergio Cortelazzo, MD, Alessandro Levis, Daniele Mattei, MD, Maria Pogliani Enrico Maria, MD, Anna Maria Scattolin, MD, Massimo Bernardi, MD, Giacomo Gianfaldoni, MD, Ernesta Audisio, MD, Arianna Masciulli, BiolSc, Renato Bassan, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2013) 122 (21): 2648.
https://doi.org/10.1182/blood.V122.21.2648.2648
Published: 2013
Journal Articles

Phase II Randomized Trial Of Radiation-Free Central Nervous System (CNS) Prophylaxis Comparing Intrathecal Triple Therapy With Liposomal Cytarabine (DepoCyte ® ) In Adult Acute Lymphoblastic Leukemia (ALL)

Renato Bassan, MD, Arianna Masciulli, BiolSc, Tamara Intermesoli, MD, Ernesta Audisio, MD, Chiara Cattaneo, MD, Enrico Maria Pogliani, MD, Vincenzo Cassibba, MD, Daniele Mattei, MD, Claudio Romani, MD, Agostino Cortelezzi, MD, Consuelo Corti, MD, Anna Maria Scattolin, MD, Orietta Spinelli, BiolSC, Manuela Tosi, BiolSC, Margherita Parolini, MD, Filippo Marmont, MD, Erika Borlenghi, MD, Monica Fumagalli, MD, Sergio Cortelazzo, MD, Andrea Gallamini, MD, Rosa Maria Marfisi, Elena Oldani, BiolSC, Roberto Marchioli, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2013) 122 (21): 3901.
https://doi.org/10.1182/blood.V122.21.3901.3901
Published: 2013
Journal Articles

High Cure Rates in Burkitt Leukemia and Lymphoma: NILG Study of the German Short Intensive Rituximab-Chemotherapy Program

Tamara Intermesoli, MD, Alessandro Rambaldi, MD, Chiara Cattaneo, MD, Federica Delaini, BiolSC, Claudio Romani, MD, Enrico Maria Pogliani, MD, Chiara Pagani, MD, Emanuele Angelucci, MD, Elisabetta Terruzzi, MD, Alessandro Levis, MD, Vincenzo Cassibba, MD, Daniele Mattei, MD, Giacomo Gianfaldoni, MD, Anna Maria Scattolin, MD, Eros Di Bona, MD, Elena Oldani, BiolSC, Margherita Parolini, MD, Nicola Gokbuget, MD, Dieter Hoelzer, MD, Renato Bassan, MD
Journal: Blood
Blood (2012) 120 (21): 1494.
https://doi.org/10.1182/blood.V120.21.1494.1494
Published: 2012
Journal Articles

Early Response Dynamics Including Minimal Residual Disease (MRD) and Adherence to Risk/MRD-Oriented Therapy Are Major Outcome Determinants in Adult Ph-Negative Acute Lymphoblastic Leukemia (ALL).

Renato Bassan, MD, Orietta Spinelli, BiolSC, Elena Oldani, BiolSC, Manuela Tosi, BiolSC, Barbara Peruta, BiolSC, Erika Borlenghi, MD, Enrico Maria Pogliani, MD, Eros Di Bona, MD, Vincenzo Cassibba, MD, Anna Maria Scattolin, MD, Claudio Romani, MD, Fabio Ciceri, MD, Agostino Cortelezzi, MD, Giacomo Gianfaldoni, MD, Daniele Mattei, MD, Ernesta Audisio, MD, Tamara Intermesoli, Alessandro Rambaldi, MD
Journal: Blood
Blood (2012) 120 (21): 2573.
https://doi.org/10.1182/blood.V120.21.2573.2573
Published: 2012
Journal Articles

In Adult Acute Lymphoblastic Leukemia (ALL) Different Minimal Residual Disease (MRD) Levels Predict Clinical Outcome in All Patients and Response to Allogeneic/Autologous Transplantation in MRD-Positive Patients.

Renato Bassan, MD, Orietta Spinelli, BiolSC, Elena Oldani, BiolSC, Manuela Tosi, BiolSC, Barbara Peruta, BiolSC, Erika Borlenghi, MD, Enrico Maria Pogliani, MD, Eros Di Bona, MD, Vincenzo Cassibba, MD, Anna Maria Scattolin, MD, Claudio Romani, MD, Fabio Ciceri, MD, Agostino Cortelezzi, MD, Giacomo Gianfaldoni, MD, Daniele Mattei, MD, Ernesta Audisio, MD, Tamara Intermesoli, Alessandro Rambaldi, MD
Journal: Blood
Blood (2012) 120 (21): 2493.
https://doi.org/10.1182/blood.V120.21.2493.2493
Published: 2012